Search | Page 14 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    ... Thiotepa 5 mg/kg/day x 2 or 10 mg/kg/day x 1 Drug: Cyclophosphamide 60 mg/ kg/day x 2 (or fludarabine 25mg/m2 x 5 if cyclophosphamide is contraindicated). Drug: Busulfan 0.8 mg/kg every ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  2. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    ... infusion over 30 minutes, daily On days -6, -5, -4, and -3 Cyclophosphamide:1200 mg/m2 per day IV infusion over 2 hours on Days 6, -5, -4, ... day continuous IV infusion over 24 hours daily on days 1-4 Cyclophosphamide: 750 mg/m2 IV infusion over 30 minutes on day 5 Prednisone:60 ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.

  3. Clinical Trials Report for June 2015

    ... GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a ... and benefit of giving a type of chemotherapy - cyclophosphamide - after the transplant to prevent graft versus host disease ...

    Page last updated 06/18/2015 - 11:47am.

  4. Clinical Trials Report for July 2015

    ... GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a ... and benefit of giving a type of chemotherapy - cyclophosphamide - after the transplant to prevent graft versus host disease ...

    Page last updated 06/24/2015 - 1:43pm.

  5. Clinical Trials Report for May 2015

    ... GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a ... and benefit of giving a type of chemotherapy - cyclophosphamide - after the transplant to prevent graft versus host disease ...

    Page last updated 04/28/2015 - 11:38am.

  6. Research Retrospective for AA&MDSIF 30th Anniversary - Dr. Neal Young

    ... is more intensive immuosuppresion using rabbit ATG or cyclophosphamide . I think those have yielded disappointing results. It is ...

    Interview last updated 05/08/2013 - 2:51pm.

  7. North American Pediatric Aplastic Anemia Consortium Symposium

    ... sibling transplant in SAA with a conditioning regimen of Cyclophosphamide and ATG at 3 years is 90%. The typical time to transplant ...

    Page last updated 10/31/2013 - 4:06pm.

  8. Transplantation Update

    ... is it possible to reduce or even completely avoid cyclophosphamide (Cytoxan®) by instead using fludarabine , ... showed that this can work, but we can’t completely omit cyclophosphamide because there was failure of engraftment when this ...

    Interview last updated 05/14/2015 - 2:42pm.

  9. Interviews with the Experts Transplantation & GVHD: What Patients Need to Know

    ... dose regimen might consist of busulfan combined with cyclophosphamide (Cytoxan®), while a low intensity regimen might consist ...

    Interview last updated 09/30/2014 - 11:07am.

  10. Transplantation Basics

    ... dose regimen might consist of busulfan combined with cyclophosphamide (Cytoxan®), while a low intensity regimen might consist ...

    Interview last updated 04/05/2013 - 2:33pm.